GlaxoSmithKline reported 2.2B in EBITDA for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Alcon AG ALC:SW 707M 223M
AstraZeneca AZN:LN 5509M 2725M
Fresenius FRE:GR € 1919M 208M
GRIFOLS GRF:SM € 330.18M 44.07M
Hikma Pharmaceutical HIK:LN 369M 11M
Lonza Group LONN:SW 811M 36M
Novartis NOVN:VX SF 4214M 623M
Philips PHIA:NA € 922M 168M
Recordati REC:IM € 147.44M 2.75M